top of page

European Health Catapult BioTech finalist selected

Seven start-ups will pitch at the EIT Health Summit

Cartana, Iproteos S.L., OmniSpirant Limited, SparingVision, Takis, uFraction8, Yesse Technologies

The first of the three European Health Catapult (EHC) Semifinals took place in Delft, The Netherlands on 24-26 September 2019. The BioTech semifinal was organised by TU Delft and hosted by Biotech Campus Delft and DSM. A total of 13 exceptional biotech start-ups participated in a two-day intensive training aimed at strengthening their value proposition and improving their pitching skills.

On the third day, which was combined with the EIT Health Investor Forum, the EHC start-ups gave a pitch in front of an investor jury. In total, the BioTech Catapult Semifinalists asked for approximately €112 million for future investments. In the afternoon, the start-ups had an opportunity to network and establish further connections with investors and health industry representatives.

Bart Haex, Business Creation Manager EIT Health Belgium-Netherlands: “The EHC-competition is a unique chance for start-ups to introduce themselves for the European health & healtcare sectors and to meet with intersting research institutes, companies and investors.”

The EHC investor jury selected seven BioTech start-ups to go through to the finals of the European Health Catapult competition which will be held during the EIT Health Summit on 2-3 December 20189 in Paris, France. There they will be joined by MedTech and Digital Health start-ups and all the finalists will pitch their innovations to compete for recognition, the attention of investors and prizes worth a total of €210 000.


bottom of page